SYDNEY GRAYBILL: Open Payments
NPI 1912780834 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 28 payments from 8 companies in 2025. Trend: 2023 $19 · 2024 $534 · 2025 $578
Food & beverage: $560Education: $19
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $184 |
| AstraZeneca Pharmaceuticals LP | 5 | $153 |
| PFIZER INC. | 5 | $87 |
| ABBVIE INC. | 2 | $37 |
| Novo Nordisk Inc | 2 | $36 |
| Exact Sciences Corporation | 2 | $33 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: MOUNJARO, FARXIGA, AIRSUPRA, ELIQUIS, Ozempic, PREVNAR 20, Cologuard Collection Kit, QULIPTA.
Industry payments across FL — which companies pay providers there.
